These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3170132)

  • 1. Acute leukemia occurring after radiotherapy and chemotherapy with a nitrosourea, PCNU.
    Shepard KV; Larson R; Le Beau MM; Leichman L; Levin B
    Invest New Drugs; 1988 Jun; 6(2):121-4. PubMed ID: 3170132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case report: acute leukemia after semustine (methyl-CCNU) therapy.
    Uphouse WJ; Oishi N
    Cancer Treat Rep; 1982 Jul; 66(7):1593-4. PubMed ID: 6953997
    [No Abstract]   [Full Text] [Related]  

  • 3. PCNU: phase II evaluation in advanced colorectal carcinoma.
    Pazdur R; Samson MK; Baker LH
    Invest New Drugs; 1988 Jun; 6(2):93-5. PubMed ID: 3170134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II trial of PCNU in advanced colorectal carcinoma. An Eastern Cooperative Oncology Group pilot study.
    Earhart RH; Moertel C; Hahn RG; Woodhouse CL; Ramirez G; Engstrom PF
    Am J Clin Oncol; 1984 Aug; 7(4):309-12. PubMed ID: 6741861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute myeloid leukemia secondary to oxaliplatin treatment for esophageal cancer.
    Damodaran S; Bellavia T; Sait SN; Wang ES; Wetzler M; Khushalani NI
    Clin Colorectal Cancer; 2012 Jun; 11(2):151-4. PubMed ID: 22133502
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute nonlymphocytic leukemia associated with nitrosourea chemotherapy: report of two cases.
    Cohen RJ; Wiernik PH; Walker MD
    Cancer Treat Rep; 1976 Sep; 60(9):1257-61. PubMed ID: 1071015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer and secondary leukemia.
    Rosner F
    Bull Cancer; 1983; 70(1):55-60. PubMed ID: 6573207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PCNU in advanced adenocarcinoma of the ovary: a phase II study.
    Decker DA; Samson MJ; Baker LH
    Cancer Treat Rep; 1983 May; 67(5):511-2. PubMed ID: 6850668
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapy of advanced gastrointestinal cancer with the nitrosoureas.
    Moertel CG
    Cancer Chemother Rep 3; 1973 May; 4(3):27-34. PubMed ID: 4748872
    [No Abstract]   [Full Text] [Related]  

  • 10. Fludarabine and cytarabine versus high-dose cytarabine in consolidation treatment of t(8; 21) acute myeloid leukemia: A prospective, randomized study.
    Li R; Hu X; Wang L; Cheng H; Lv S; Zhang W; Wang J; Yang J; Song X
    Am J Hematol; 2017 Jan; 92(1):12-17. PubMed ID: 27673579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy-related acute leukemia with mixed phenotype and t(9;22)(q32;q11.2): a case report and review of the literature.
    Cho JH; Hur M; Moon HW; Yun YM; Ko YS; Kim WS; Lee MH
    Hum Pathol; 2012 Apr; 43(4):605-9. PubMed ID: 22036054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary leukemia with a translocation (8;21)?
    Davies SV; Murray JA; Bowser-Riley SM
    Cancer Genet Cytogenet; 1988 Apr; 31(2):271-4. PubMed ID: 3162399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosomes and causation of human cancer and leukemia. IX. Prognostic and therapeutic value of chromosomal findings in acute myeloblastic leukemia.
    Sakurai M; Sandberg AA
    Cancer; 1974 Jun; 33(6):1548-57. PubMed ID: 4525996
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute myeloblastic leukemia (M0) with an unusual chromosomal abnormality: translocation (1;14)(p13;q32).
    Tecimer C; Loy BA; Martin AW
    Cancer Genet Cytogenet; 1999 Jun; 111(2):175-7. PubMed ID: 10347560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea in small cell cancer of the lung.
    Chapman RA; Natale RB; Young CW; Wittes RE
    Am J Clin Oncol; 1984 Oct; 7(5):413-4. PubMed ID: 6095639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lethal activity and repair inhibition capacity of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (NSC 95466, PCNU), a nitrosourea with low carbamoylating activity.
    Drewinko B; Yang LY
    Invest New Drugs; 1983; 1(3):197-202. PubMed ID: 6678867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective chemotherapy of acute myelocytic leukemia occurring after alkylating agent or radiation therapy for prior malignancy.
    Vaughan WP; Karp JE; Burke PJ
    J Clin Oncol; 1983 Mar; 1(3):204-7. PubMed ID: 6366134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [High-dose cytarabine treatment in acute leukemias and leukemic meningiosis: clinical aspects and pharmacokinetics].
    Nowrousian MR; Seeber S; Miller AA; Anders C; Ohl S; Schmidt CG
    Onkologie; 1985 Feb; 8(1):26-32. PubMed ID: 3885117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary acute myeloid leukemia with inv(16): report of two cases following paclitaxel-containing chemotherapy and review of the role of intensified ara-C therapy.
    Seymour JF; Juneja SK; Campbell LJ; Ellims PH; Estey EH; Prince HM
    Leukemia; 1999 Nov; 13(11):1735-40. PubMed ID: 10557046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trail of PCNU in refractory advanced breast cancer.
    Kavanagh JJ; Yap HY; Blumenschein GR; Stewart D; Bodey GP
    Am J Clin Oncol; 1982 Jun; 5(3):249-51. PubMed ID: 7081144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.